<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Science and Innovations in Medicine</journal-id><journal-title-group><journal-title xml:lang="en">Science and Innovations in Medicine</journal-title><trans-title-group xml:lang="ru"><trans-title>Наука и инновации в медицине</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2500-1388</issn><issn publication-format="electronic">2618-754X</issn><publisher><publisher-name xml:lang="en">FSBEI of Higher Education SamSMU of Ministry of Health of the Russian Federation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">82524</article-id><article-id pub-id-type="doi">10.35693/2500-1388-2022-7-1-9-12</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Human Anatomy</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Анатомия человека</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Phase contents of bone mineral of the hipbone in streptozotocin-induced diabetic pre-senile rats after surgical perforation of the tibia</article-title><trans-title-group xml:lang="ru"><trans-title>Фазовый состав биоминерала тазовой кости у белых крыс предстарческого возраста со стрептозотоцин-индуцированным диабетом после хирургической перфорации большеберцовых костей</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6341-5746</contrib-id><name-alternatives><name xml:lang="en"><surname>Torba</surname><given-names>Aleksandr V.</given-names></name><name xml:lang="ru"><surname>Торба</surname><given-names>Александр Владимирович</given-names></name></name-alternatives><address><country country="LP">Luhansk People's Republic</country></address><bio xml:lang="en"><p>PhD, Associate Professor, Head of the Department of Hospital Surgery, urology and oncology</p></bio><bio xml:lang="ru"><p>канд. мед. наук, доцент, заведующий кафедрой госпитальной хирургии, урологии и онкологии</p></bio><email>alexandr_v_torba@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Saint Luka Lugansk State Medical University</institution></aff><aff><institution xml:lang="ru">ГУ «Луганский государственный медицинский университет имени Святителя Луки»</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2022-01-15" publication-format="electronic"><day>15</day><month>01</month><year>2022</year></pub-date><volume>7</volume><issue>1</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>9</fpage><lpage>12</lpage><history><date date-type="received" iso-8601-date="2021-10-06"><day>06</day><month>10</month><year>2021</year></date><date date-type="accepted" iso-8601-date="2022-01-14"><day>14</day><month>01</month><year>2022</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2021, Torba A.V.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2021, Торба А.В.</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="en">Torba A.V.</copyright-holder><copyright-holder xml:lang="ru">Торба А.В.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://innoscience.ru/2500-1388/article/view/82524">https://innoscience.ru/2500-1388/article/view/82524</self-uri><abstract xml:lang="en"><p><bold>Aim</bold> – to investigate changes in phase contents of bone mineral of the hipbone in pre-senile streptozotocin-induced diabetic rats after surgical perforation of the tibia.</p> <p><bold>Material and methods.</bold> Diabetes was induced in 35 animals with an initial weight of 290-310 g at the age of 17-18 months by a single intraperitoneal injection of streptozotocin in dosage of 55 mg per kg of body weight. Surgical perforation of the tibia was modeled as 2.0 mm opening in the proximal metadiaphysis (35 animals). Another group comprised 35 animals with both perforation and diabetes. 35 intact animals comprised the control group. The content of whitlockite, calcite and hydroxylapatite in bone mineral of the hipbone was determined.</p> <p><bold>Results.</bold> Surgical perforation of the tibia resulted in instability of phase contents of bone mineral of the hipbone by the 15th day of observation; peak of deviations was registered on the 90th day of observation, when the proportions of whitlockite and calcite increased by 7.20% and 8.91%, while the proportions of hydroxyapatite decreased by 3.53% in comparison with the controls. In diabetic animals, the destabilization of the phase composition of bone mineral was observed by the 7th day of the experiment. By the 90th day, the proportion of whitlockite and calcite exceeded those of the controls by 9.00% and 9.01% while the proportion of hydroxylapatite decreased by 4.00%. Surgical perforation of the tibia in diabetic pre-senile animals resulted in more marked increase of hipbone mineral amorphousness from the 7th day of observation; by the 90th day the proportion of whitlockite exceeded this in rats with perforation by 7.95%, while the proportion of hydroxylapatite decreased by 2.35%.</p> <p><bold>Conclusion.</bold> Surgical perforation of the tibia in diabetic pre-senile rats results in increasing of the amorphousness of bone mineral of the hipbone, which grows starting from the 7th day after operation.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Цель</bold> – установить динамику изменения фазового состава биоминерала тазовой кости у крыс предстарческого возраста со стрептозотоцин-индуцированным диабетом после хирургической перфорации большеберцовых костей.</p> <p><bold>Материал и методы.</bold> Сахарный диабет индуцировали однократным внутрибрюшинным введением стрептозотоцина в дозе 55 мг/кг (35 крыс с исходной массой 290–310 г в возрасте 17–18 месяцев). Хирургическую перфорацию большеберцовых костей диаметром 2,0 мм производили в проксимальном метадиафизе большеберцовых костей (35 крыс). Части животных (35 крыс) перфорацию большеберцовых костей производили после индуцирования сахарного диабета. Контролем служили интактные животные (35 крыс). Определяли содержание в биоминерале тазовой кости витлокита, кальцита и гидроксилапатита.</p> <p><bold>Результаты.</bold> Хирургическая перфорация большеберцовых костей приводила к дестабилизации фазового состава тазовых костей с 15 суток после операции с пиком отклонений к 90 суткам, когда доли витлокита и кальцита превышали контроль на 7,20% и 8,91%, а доля гидроксилапатита снижалась на 3,53%. При стрептозотоцин-индуцированном диабете фазовый состав тазовых костей дестабилизировался с 7-х суток; к 90-м суткам доли витлокита и кальцита превышали контроль на 9,00% и 9,01%, а доля гидроксилапатита снижалась на 4,00%. Сочетание перфорации большеберцовых кости и стрептозотоцин-индуцированного диабета приводило к усугублению аморфности фазового состава тазовых костей с 7-х суток, к 90-м суткам эксперимента доля витлокита превышала значения группы с изолированной перфорацией большеберцовых костей на 7,95%, а доля гидроксилапатита снижалась на 2,35%.</p> <p><bold>Заключение.</bold> Хирургическая перфорация большеберцовых костей при стрептозотоцин-индуцированном диабете у крыс предстарческого возраста приводит к усугублению аморфности биологического минерала тазовых костей с 7-х суток после манипуляции.</p></trans-abstract><kwd-group xml:lang="en"><kwd>pre-senile rats</kwd><kwd>streptozotocin-induced diabetes</kwd><kwd>bone fracture</kwd><kwd>bone biomineral</kwd><kwd>X-ray phase analysis</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>крысы предстарческого возраста</kwd><kwd>стрептозотоциновый диабет</kwd><kwd>повреждение кости</kwd><kwd>костный биоминерал</kwd><kwd>фазовый рентгеноструктурный анализ</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Romero-Díaz C, Duarte-Montero D, Gutiérrez-Romero SA, Mendivil CO. Diabetes and Bone Fragility. Diabetes Ther. 2021;12(1):71–86. doi: 10.1007/s13300-020-00964-1. PMID: 33185853</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Zhukouskaya VV, Eller-Vainicher C, Shepelkevich AP, et al. Bone health in type 1 diabetes: focus on evaluation and treatment in clinical practice. J Endocrinol Invest. 2015;38(9):941–950. doi: 10.1007/s40618-015-0284-9. PMID: 25863666</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Kanazawa I, Sugimoto T. Diabetes Mellitus-induced Bone Fragility. Intern Med. 2018;57(19):2773–2785. doi: 10.2169/internalmedicine.0905-18. PMID: 29780142</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Laugesen E, Østergaard JA, Leslie RDG. Latent autoimmune diabetes of the adult: current knowledge and uncertainty. Diabet Med. 2015;32(7):843–852. doi: 10.1111/dme.12700. PMID: 25601320</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Fadiga L, Saraiva J, Catarino D, et al. Adult-onset autoimmune diabetes: comparative analysis of classical and latent presentation. Diabetol Metab Syndr. 2020;12:107. doi: 10.1186/s13098-020-00616-1 PMID: 33292447</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Shah VN, Carpenter RD, Ferguson VL, Schwartz AV. Bone health in type 1 diabetes. Curr Opin Endocrinol Diabetes Obes. 2018;25(4):231–236. doi: 10.1097/MED.0000000000000421 PMID: 29794498</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Costantini S, Conte C. Bone health in diabetes and prediabetes. World J Diabetes. 2019;10(8):421–445. doi: 10.4239/wjd.v10.i8.421 PMID: 23798298</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Rees DA, Alcolado JC. Animal models of diabetes mellitus. Diabet Med. 2005;22(4):359–370. doi: 10.1111/j.1464-5491.2005.01499.x PMID: 15787657</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Kolb VG, Kamyshnikov VS. Clinical Chemistry Handbook. Minsk, 1982. (In Russ.). [Колб В.Г., Камышников В.С. Справочник по клинической химии. Минск, 1982].</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Mirkin LI. X-ray analysis. Indexing radiographs. Moscow, 1981. (In Russ.). Миркин Л.И. Рентгеноструктурный анализ. Индицирование рентгенограмм. М., 1981].</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Luzin VI. Application of X-ray analysis to study the phase composition of bone mineral. Ukrainian morphological almanac. 2005;3(4):61–64. (In Russ.). [Лузин В.И. Применение рентгеноструктурного анализа для исследования фазового состава костного минерала. Український морфологічний альманах. 2005;3(4):61–64].</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Emami AJ, Toupadakis CA, Telek SM, et al. Age dependence of systemic bone loss and recovery following femur fracture in mice. J Bone Miner Res. 2019;34(1):157–170. doi: 10.1002/jbmr.3579 PMID: 30189111</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Domazetovic V, Marcucci G, Iantomasi T, et al. Oxidative stress in bone remodeling: role of antioxidants. Clin Cases Miner Bone Metab. 2017;14(2):209–216. doi: 10.11138/ccmbm/2017.14.1.209 PMID: 29263736</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Yamamoto M, Sugimoto T. Advanced glycation end products, diabetes, and bone strength. Curr Osteoporos Rep. 2016;14(6):320–326. doi: 10.1007/s11914-016-0332-1 PMID: 27704396</mixed-citation></ref></ref-list></back></article>
